This regulation is bidirectional: the peptide can increase or decrease NO production depending on the pathological context, thereby contributing to vascular protection and inflammation reduction
At 2.5mg per week, a 10mg vial with 2ml of water provides exactly four doses
GHK-Cu is not approved or licensed by the MHRA as a treatment for hair loss in the UK, and it is not included in NICE or NHS guidance
To our knowledge, we are the first to report that nuclear GSTP functions as a negative regulator to control HMGB1 release from macrophages and decreases the mortality of sepsis
It also leaves you vulnerable to disease-causing bacteria, and increases the risk of conditions such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), obesity, diabetes, cardiovascular issues, cancer and more